08.08.12
Charles River Laboratories
2Q Revenues: $284.7 million (-1%)
2Q Earnings: $30.6 million (-6%)
YTD Revenues: $570.7 million (flat)
YTD Earnings: $57.1 million (-11%)
Comments: Research Models and Services sales were $173.6 million in quarter (-3%). Foreign exchange impacted sales by 3.8%. Preclinical Services sales were $111.1 million (+1%). Foreign currency exchange reduced sales by 2.1%.
2Q Revenues: $284.7 million (-1%)
2Q Earnings: $30.6 million (-6%)
YTD Revenues: $570.7 million (flat)
YTD Earnings: $57.1 million (-11%)
Comments: Research Models and Services sales were $173.6 million in quarter (-3%). Foreign exchange impacted sales by 3.8%. Preclinical Services sales were $111.1 million (+1%). Foreign currency exchange reduced sales by 2.1%.